We are live on ! Find out more
BL

Bleichroeder LP Portfolio holdings

AUM $559M
1-Year Est. Return 83.7%
This Fund
S&P 500
This Quarter Est. Return
+6.64%
1 Year Est. Return
+83.7%
3 Year Est. Return
+202.15%
5 Year Est. Return
+208.71%
10 Year Est. Return
–
AUM
$493M
AUM Growth
+$24M
Cap. Flow
+$24.3M
Cap. Flow %
4.93%
Top 10 Hldgs %
73.64%
Holding
90
New
10
Increased
4
Reduced
3
Closed
7

Top Buys

Rank Stock Value
1
FNA
Paragon 28, Inc.
FNA
+$31.7M
2
INSM icon
Insmed
INSM
+$5.68M
3
ASH icon
Ashland
ASH
+$3.75M
4
DFLI icon
Dragonfly Energy
DFLI
+$2.48M
5
DD icon
DuPont de Nemours
DD
+$2.48M

Top Sells

Rank Stock Value
1
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
+$16.4M
2
THO icon
Thor Industries
THO
+$12.4M
3
BRIV
B. Riley Principal 250 Merger Corp. Class A common stock
BRIV
+$2.29M
4
FNCH
Finch Therapeutics Group, Inc. Common Stock
FNCH
+$267K
5
ISPC icon
iSpecimen
ISPC
+$88.2K

Sector Composition

Rank Sector Weight
1 Healthcare 24.15%
2 Consumer Discretionary 18.86%
3 Miscellaneous 17.38%
4 Industrials 13.81%
5 Materials 10.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GLD icon
1
SPDR Gold Trust
GLD
$149B
$84.7M 17.18%
475,000
– –
BC icon
2
Brunswick
BC
$4.97B
$84.5M 17.15%
975,636
– –
LIN icon
3
Linde
LIN
$226B
$44.4M 9.01%
116,564
– –
FNA
4
DELISTED
Paragon 28, Inc.
FNA
$26.8M 5.44%
+1,763,339
New +$31.7M
INVE icon
5
Identive
INVE
$66.9M
$24.3M 4.92%
2,884,495
+275,000
+11% +$1.88M
PROK icon
6
ProKidney
PROK
$382M
$22.4M 4.54%
2,000,000
– –
GPGI
7
GPGI Inc
GPGI
$3.84B
$20.5M 4.16%
3,599,298
– –
MRNS
8
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$20.3M 4.13%
1,872,463
– –
IVAC
9
DELISTED
Intevac Inc
IVAC
$18.9M 3.83%
5,039,023
– –
SPGI icon
10
S&P Global
SPGI
$131B
$16M 3.25%
40,000
– –
DRRX
11
DELISTED
DURECT Corp
DRRX
$13.1M 2.65%
2,637,965
– –
CORS
12
DELISTED
Corsair Partnering Corporation
CORS
$12.9M 2.63%
1,250,000
– –
MDXH icon
13
MDxHealth
MDXH
$68.8M
$11.8M 2.39%
3,458,333
– –
THO icon
14
Thor Industries
THO
$4.01B
$8.41M 1.71%
81,250
-146,250
-64% -$12.4M
DUOT icon
15
Duos Technologies
DUOT
$294M
$7.62M 1.55%
1,283,162
– –
BX icon
16
Blackstone
BX
$107B
$7.44M 1.51%
80,000
– –
INSM icon
17
Insmed
INSM
$25.9B
$6.86M 1.39%
325,000
+299,399
+1,169% +$5.68M
TV icon
18
Televisa
TV
$1.45B
$5.13M 1.04%
1,000,000
– –
IDN icon
19
Intellicheck
IDN
$57.6M
$5.12M 1.04%
2,073,583
– –
OPTN
20
DELISTED
OptiNose
OPTN
$4.98M 1.01%
269,675
– –
JPM icon
21
JPMorgan Chase
JPM
$951B
$4.36M 0.89%
30,000
– –
AXP icon
22
American Express
AXP
$225B
$4.36M 0.88%
25,000
– –
MIST icon
23
Milestone Pharmaceuticals
MIST
$144M
$3.78M 0.77%
1,326,085
– –
ASH icon
24
Ashland
ASH
$3.41B
$3.53M 0.72%
+40,602
New +$3.75M
CUE icon
25
Cue Biopharma
CUE
$203M
$2.76M 0.56%
25,168
– –
1
2 3 4

Similar funds

NFW
Noble Family Wealth Clearwater, Florida $559M AUM 24.35% 1-Year Est. Return
IRC
Investors Research Corp Atlanta, Georgia $559M AUM 21.55% 1-Year Est. Return
SCM
Soros Capital Management New York $559M AUM 171.77% 1-Year Est. Return
PHC
Palidye Holdings (Caymans) Grand Cayman, Cayman Islands $559M AUM 1.08% 1-Year Est. Return
EPM
Equitec Proprietary Markets Chicago, Illinois $559M AUM 230.29% 1-Year Est. Return
BCM
Brasada Capital Management Houston, Texas $558M AUM 21.68% 1-Year Est. Return
FAM
Frontier Asset Management Sheridan, Wyoming $558M AUM 22.41% 1-Year Est. Return
WDG
Wealth Dimensions Group Cincinnati, Ohio $558M AUM 20.63% 1-Year Est. Return

Bleichroeder LP's Q2 2023 Portfolio in Review

As of Q2 2023, Bleichroeder LP held 90 positions worth $493M, up 5.1% from $469M the previous quarter. Its ten largest holdings account for 74% of the portfolio.

Bleichroeder LP deployed $24.3M of net new capital in Q2 2023, opening 10 new positions and adding to 4 existing holdings. Its largest new stake was Paragon 28, Inc.: 1,763,339 shares worth $26.8M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Miscellaneous.

On the sell side, the largest reduction was Thor Industries, an estimated $12.4M trimmed.

  • Bleichroeder LP's largest Q2 2023 buy was Paragon 28, Inc.: 1,763,339 shares worth $26.8M.
  • Bleichroeder LP added most to Insmed in Q2 2023, an estimated $5.68M increase.
  • Bleichroeder LP's biggest Q2 2023 reduction was Thor Industries, cutting an estimated $12.4M.
  • Bleichroeder LP fully exited CTI BioPharma Corp. (DE) Common Stock in Q2 2023, selling an estimated $16.4M.
  • Bleichroeder LP's ten largest holdings make up 74% of its $493M portfolio in Q2 2023.
  • Bleichroeder LP opened 10 new positions and closed 7 in Q2 2023.
  • Bleichroeder LP's portfolio value rose 5.1% quarter-over-quarter to $493M.

Based on Bleichroeder LP's 13F filing for Q2 2023, filed 14 Aug 2023.